Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for lung cancer. Another look; a different view

G M Strauss1, R E Gleason, D J Sugarbaker

  • 1Division of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.

Chest
|March 1, 1997
PubMed
Summary

Lung cancer screening with chest X-rays (CXRs) shows improved survival and stage distribution. While mortality reductions aren't proven, CXR screening may benefit high-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

The impact of a prior history of cardiovascular events on outcomes in patients on renal replacement therapy.

International journal of cardiology·2012
Same author

The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance.

Cell death & disease·2011
Same author

AXL regulates mesothelioma proliferation and invasiveness.

Oncogene·2010
Same author

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.

British journal of cancer·2008
Same author

A microaliquoting technique for precise histological annotation and optimization of cell content in frozen tissue specimens.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2007

Area of Science:

  • Pulmonary Medicine
  • Oncology
  • Diagnostic Imaging

Background:

  • Four randomized controlled trials (RCTs) on lung cancer screening have been conducted.
  • Early studies (Memorial-Sloan Kettering, Johns Hopkins) compared chest radiographs (CXRs) with CXRs plus sputum cytology, finding no outcome difference but unexpectedly high survival.
  • Subsequent RCTs (Mayo Lung Project, Czechoslovak study) compared frequent CXR screening with less frequent screening.

Purpose of the Study:

  • To review prospective studies on lung cancer screening.
  • To analyze potential biases influencing observed screening trial results.

Main Methods:

  • Review of prospective lung cancer screening studies, focusing on randomized controlled trials.
  • Analysis of potential biases including overdiagnosis, lead-time, and length bias.
  • Examination of mortality data in relation to survival and fatality rates.

Main Results:

  • The Mayo and Czechoslovak studies showed significant advantages for screening in stage distribution, resectability, survival, and fatality.
  • Despite improved survival/fatality, mortality was paradoxically higher in screened groups.
  • Biases like overdiagnosis, lead-time, and length bias were investigated and found insufficient to explain outcome discrepancies; population heterogeneity is proposed as an alternative explanation.

Conclusions:

  • Periodic chest X-ray (CXR) screening offers clinically meaningful improvements in lung cancer stage distribution, resectability, survival, and fatality.
  • Mortality reductions were not demonstrated, but mortality data in key trials may not accurately reflect lung cancer death rates.
  • Reconsideration of periodic CXR screening for individuals at high risk for lung cancer is warranted.

Related Experiment Videos